Clinical evaluation of the effect OF Siddha medicine KANAI ENNAI for the treatment of BREATHING DIFFICULTY

Clinical evaluation of the effect of KANAI ENNAI for the management of NEER MANTHA KANAM .

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019811

Enrollment

Registered

2019-06-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: kanai ennai: Dosage 5-10ml and should be administered orally twice a day after food for a period of 5 to 7 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with any of the following symptoms will be included in the study 1. Dyspnoea 2. Lethargy 3. Decreased appetite 4. Fever 5. Sore throat 6. Nasal congestion Expiratory sounds like stridor,turbulence,consolidation,rhonchi,rales are included

Exclusion criteria

Exclusion criteria: Disease which required immediate medical attention such as 1. Pneumonia 2. Jaundice 3. Congenital Heart Disease 4. Acute severe Asthma will be excluded from the study

Design outcomes

Primary

Measure	Time frame
Post nasal discharge,dry cough,malaise,anorexia,abdominal disturbanceTimepoint: 3 to 5 days	—

Secondary

Measure	Time frame
Eosinophil count ESR RateTimepoint: 7 to 10 days	—

Countries

India

Contacts

Public ContactK Shyamala

Government Siddha Medical College and Hospital Palayamkottai

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026